Acumen Research and Consulting estimate that global Adhesion Barrier Market is expected to reach the market value of around US$ 1.4 Bn by 2027 and is projected to grow at a CAGR of around 7% in terms of revenue amid the forecast period 2020 – 2027.
A barrier to adhesion is used to reduce an irregular skin scar by removing internal tissues and organs after the surgery. Adhesion inhibitors are used for gastrointestinal, orthopedic, reconstructive, neurological and urological procedures and mainly used to heal the coronary artery in cardiovascular surgeries. In comparison with the liquid formulation, the gel and film formulations of adhesion barriers are widely used.
The report provides analysis of global Adhesion Barrier market for the period 2016-2027, wherein 2020 to 2027 is the forecast period and 2019 is considered as the base year.
Over recent years the number of surgeries carried out globally has significantly grown, with the incidence of chronic illnesses and other health problems. A variety of surgical procedures such as gynecological and abdominal surgeries employ film, gel and liquid adhesion avoidance formulations. These formulations are used at the operating site for the separation of internal tissues and organs and for postoperative adhesion prevention. Therefore, the traumatized tissue surfacing and tissue regeneration strengthen their function as a physical shield. As the number of operations carried out worldwide is increasing, the demand for these products increases.
Around 313 million surgeries are carried out worldwide each year as per The Lancet. The number of chronic diseases such as cardiovascular diseases and arthritis is expected to increase in future years. Growing number traumatic incidents requiring surgical interventions is also driving the adhesion barriers market.
In fact, rising demand for such items grows with the prevalence of sport injuries. The most frequent types of sports injuries reported worldwide are sprains and strains. Stanford Children's Health (SFH) estimates that over 3.5 million US accidents occur in 30 million children who are involved in any competitive sport and one third of all incidents that take place when they are in childhood. The increase in the amount of surgical procedure for sport injury care therefore increases the demand for adhesion protection products, which in turn induces a business rise in the adhesion barrier.
The legal criteria for medical devices membership are dynamic and complicated, mainly due to their related legal aspects. In order for the safety of the population to be guaranteed, quality and the performance of medical devices are required facets. Therefore, the association with medical instruments is met with specific and stringent criteria.
Resorbable adhesion barrier as specified in 21 Code for Regulations (CFR) 812.3(m)(4) is an essential risk apparatus, according to the United States Food and Drug Administration (USFDA). Class III products, which are expected to undergo different certification procedures, such as the USFDA, including investigation application exemptions (IDEs), premarket certification (PMAs), and product development protocol (PDPs), provide a resorbable adhesion barrier. As the regulatory process sometimes takes too many times for medical device approval, these devices are hampered by research and development (R&D). Therefore, the expansion of the accession barrier market to a certain degree restricts specific regulatory criteria.
Despite of the involvement of leading companies such as Johnson and Johnson, Baxter International, Integra LifeSciences, Anika Therapeutics and FzioMed, North America leads the market. The demand in the Asia Pacific is expected to expand lucratively amid the projected era. The region's strong growth rate is attributable to growing geriatric population and the rising cardiac and neurosurgical surgeries. The area is also projected to be powered by increasing private sector investment in healthcare and by fast-growing medical tourism. High development is anticipated to contribute to the region during the projected period in major countries such as India, China and Japan.
Adhesion Barrier Market By Type
Synthetic Adhesion Barriers
Natural Adhesion Barriers
Adhesion Barrier Market By Formulation
Adhesion Barrier Market By Surgeries
Adhesion Barrier Market By Region
Middle East & Africa
The adhesion barrier system market value is anticipated to be worth around US$ 1.4 Bn in 2027
The adhesion barrier market is anticipated to grow around 7% CAGR amid the forecast period 2020-2027.
North America held highest market share in 2019
Asia Pacific is projected to be the fastest growing region in the global market.
Growing number of surgeries worldwide, growing chronic illness and traumatic conditions needing surgical interventions are driving the market
Synthetic Adhesion Barriers is the fastest growing segment by product type
Participants include major global players Atrium Medical Corporation, Johnson & Johnson, Medtronic Plc., FzioMed, Inc., Integra Lifesciences Corporation, Getinge AB, Sanofi Group, Baxter International Inc., Anika Therapeutics Inc., C. R. Bard, Inc., and Others